Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.76
(
-0.88%
)
Bitcoin
73,936.84
(
-0.01%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 74691

Thursday, 03/19/2009 9:29:31 AM

Thursday, March 19, 2009 9:29:31 AM

Post# of 257253
Xarelto panel real-time update: Based on JNJ’s presentation so far, I think the liver-toxicity (“ghost of Exanta”) issue will turn out to be a non-issue. JNJ’s presenter just showed some compelling graphs relating to Hy’s Law.

There has not yet been any discussion of Xarelto’s bleeding risk.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today